Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6616 to 6630 of 7691 results

  1. Improving outcomes in haemato-oncology cancer (CSG3)

    This guidance has been updated and replaced by NICE guideline NG47.

    Cancer service guideline
    Published
    22 October 2003

  2. Improving outcomes in colorectal cancer (CSG5)

    This guidance has been updated and replaced by NICE guideline NG151.

    Cancer service guideline
    Published
    23 June 2004

  3. Mepilex Border dressings for preventing pressure ulcers (MIB124)

    This advice has been updated and replaced by NICE medical technologies guidance 40.

    Medtech innovation briefing
    Published
    6 October 2017

  4. Promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126)

    This advice has been replaced by NICE diagnostics guidance 36.

    Medtech innovation briefing
    Published
    27 October 2017

  5. FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care (MIB114)

    This advice has been updated and replaced by NICE medtech innovation briefing 224.

    Medtech innovation briefing
    Published
    31 July 2017

  6. ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections (MIB234)

    This advice has been updated and replaced by NICE medical technologies guidance 62.

    Medtech innovation briefing
    Published
    3 November 2020

  7. AnaConDa-S for sedation with volatile anaesthetics in intensive care (MIB229)

    This advice has been updated and replaced by NICE medical technologies guidance 65.

    Medtech innovation briefing
    Published
    6 October 2020

  8. 3C Patch System for treating diabetic foot ulcers (MIB230)

    This advice has been updated and replaced by NICE medical technologies guidance 66.

    Medtech innovation briefing
    Published
    27 October 2020

  9. KardiaMobile for the ambulatory detection of atrial fibrillation (MIB232)

    This advice has been updated and replaced by NICE medical technologies guidance 64.

    Medtech innovation briefing
    Published
    29 October 2020

  10. Synergo for non-muscle-invasive bladder cancer (MIB226)

    This advice has been updated and replaced by NICE medical technologies guidance 61.

    Medtech innovation briefing
    Published
    10 September 2020

  11. Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection (MIB247)

    This advice has been updated and replaced by NICE guideline NG199.

    Medtech innovation briefing
    Published
    2 February 2021

  12. Personal KinetiGraph for remote clinical management of Parkinson's disease (MIB258)

    This advice has been updated and replaced by NICE diagnostics guidance 51.

    Medtech innovation briefing
    Published
    4 May 2021

  13. Magtrace and Sentimag for locating sentinel lymph nodes (MIB263)

    This advice has been updated and replaced by NICE medical technologies guidance 72.

    Medtech innovation briefing
    Published
    8 June 2021

  14. SeQuent Please balloon catheter for in-stent coronary restenosis (MTG1)

    This medical technologies guidance has been replaced by the recommendations in the NICE guideline on acute coronary syndromes.

    Medical technologies guidance
    Published
    1 December 2010

  15. WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension (MTG13)

    In February 2023, NICE withdrew this guidance following a review. The original guidance published in 2013 and recommended the use of WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension. However the guidance review in 2022 recommended it be withdrawn because it was determined that: The existing medical technologies guidance was considered along with other interventions in the update of NICE's guideline on atrial fibrillation. See evidence review A and evidence review B providing the best advice to the NHS about its use. As evident in NICE's guideline on atrial fibrillation, the evidence base and experts’ advice, the landscape for opportunistically detecting atrial fibrillation in primary care has changed significantly since the original guidance, with a wider range of devices for detecting atrial fibrillation now available.

    Medical technologies guidance
    Published
    16 January 2013